We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+16.3%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$36.7B
AUM Growth
+$4.73B
Cap. Flow
+$3.45B
Cap. Flow %
9.42%
Top 10 Hldgs %
15.54%
Holding
3,403
New
385
Increased
1,787
Reduced
944
Closed
189

Sector Composition

Rank Sector Weight
1 Healthcare 9.66%
2 Technology 9.09%
3 Financials 7.96%
4 Consumer Staples 7.25%
5 Industrials 7.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CACI icon
2676
CACI
CACI
$14.2B
$269K ﹤0.01%
2,667
+12
+0.5% +$1.16K
ATHN
2677
DELISTED
Athenahealth, Inc.
ATHN
$269K ﹤0.01%
+2,132
New +$271K
AMX icon
2678
America Movil
AMX
$70.8B
$268K ﹤0.01%
23,418
-6,291
-21% -$75K
PXLW icon
2679
Pixelworks
PXLW
$41.8M
$268K ﹤0.01%
+8,008
New +$241K
TNK icon
2680
Teekay Tankers
TNK
$2.63B
$267K ﹤0.01%
13,200
+3,824
+41% +$85.7K
SGYP
2681
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$267K ﹤0.01%
+48,499
New +$227K
JPW
2682
DELISTED
Nuveen Flexible Invstment Fd
JPW
$266K ﹤0.01%
15,478
-4,391
-22% -$73.5K
CAT icon
2683
CALL
Caterpillar
CAT
$386B
$265K ﹤0.01%
30,900
-900
-3% -$73.6K
NOAH
2684
Noah Holdings
NOAH
$605M
$265K ﹤0.01%
10,140
+434
+4% +$11.3K
IEZ icon
2685
iShares US Oil Equipment & Services ETF
IEZ
$377M
$264K ﹤0.01%
6,676
-629
-9% -$23.8K
TER icon
2686
Teradyne
TER
$57.5B
$264K ﹤0.01%
12,246
+1,096
+10% +$22.6K
SLP icon
2687
Simulations Plus
SLP
$371M
$263K ﹤0.01%
+29,856
New +$248K
YRD
2688
Yiren Digital
YRD
$110M
$263K ﹤0.01%
+11,095
New +$261K
PRMW
2689
DELISTED
Primo Water Corporation
PRMW
$263K ﹤0.01%
+18,435
New +$283K
BFK
2690
DELISTED
BlackRock Municipal Income Trust
BFK
$262K ﹤0.01%
16,540
+520
+3% +$8.17K
FLC
2691
Flaherty & Crumrine Total Return Fund
FLC
$176M
$262K ﹤0.01%
12,500
-993
-7% -$21.7K
GSG icon
2692
iShares S&P GSCI Commodity-Indexed Trust
GSG
$929M
$261K ﹤0.01%
17,624
-877
-5% -$12.7K
KG
2693
Kestrel Group
KG
$70.6M
$261K ﹤0.01%
+1,030
New +$275K
AKBA icon
2694
Akebia Therapeutics
AKBA
$236M
$260K ﹤0.01%
28,746
+5,809
+25% +$49.4K
EWG icon
2695
iShares MSCI Germany ETF
EWG
$1.67B
$260K ﹤0.01%
9,886
-2,401
-20% -$61.6K
BNCN
2696
DELISTED
BNC Bancorp
BNCN
$260K ﹤0.01%
10,680
-708
-6% -$17.1K
ARIA
2697
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$260K ﹤0.01%
18,973
-31,099
-62% -$312K
XHR
2698
Xenia Hotels & Resorts
XHR
$1.73B
$259K ﹤0.01%
17,079
-130
-0.8% -$2.2K
EGO icon
2699
Eldorado Gold
EGO
$10.1B
$258K ﹤0.01%
13,110
+6,101
+87% +$126K
ZNGA
2700
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$258K ﹤0.01%
+88,701
New +$247K

Similar funds

Raymond James & Associates's Q3 2016 Portfolio in Review

As of Q3 2016, Raymond James & Associates held 3,403 positions worth $36.7B, up 15% from $31.9B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Raymond James & Associates deployed $3.45B of net new capital in Q3 2016, opening 385 new positions and adding to 1,787 existing holdings. Its largest new stake was iShares MSCI India Small-Cap ETF: 414,364 shares worth $15.2M.

By sector, the portfolio is most concentrated in Healthcare at 9.7% of assets, up from 9.6% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was TotalEnergies, an estimated $614M trimmed.

  • Raymond James & Associates's largest Q3 2016 buy was iShares MSCI India Small-Cap ETF: 414,364 shares worth $15.2M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2016, an estimated $196M increase.
  • Raymond James & Associates's biggest Q3 2016 reduction was TotalEnergies, cutting an estimated $614M.
  • Raymond James & Associates fully exited TYCO INTL PLC COM SHS (IRL) in Q3 2016, selling an estimated $61.1M.
  • Raymond James & Associates's ten largest holdings make up 16% of its $36.7B portfolio in Q3 2016.
  • Raymond James & Associates opened 385 new positions and closed 189 in Q3 2016.
  • Raymond James & Associates's portfolio value rose 15% quarter-over-quarter to $36.7B.

Based on Raymond James & Associates's 13F filing for Q3 2016, filed 14 Nov 2016.